<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
IMAB
I-Mab
$
()


  • I-Mab price target lowered by $5 at Piper Sandler, here's why

    3/18/2024 - 06:45am
  • I-Mab price target lowered by $10 at H.C. Wainwright, here's why

    3/18/2024 - 06:06am
  • I-Mab to divest assets, business operations in China fo $80M

    2/7/2024 - 06:22am
  • I-Mab granted FDA Breakthrough Therapy Designation for felzartamab

    11/2/2023 - 08:23am
  • Cantor biotech/biopharma analysts hold an analyst/industry conference call

    10/25/2023 - 12:45pm
  • Cantor biotech/biopharma analysts hold an analyst/industry conference call

    10/25/2023 - 04:55am
  • Cantor biotech/biopharma analysts hold an analyst/industry conference call

    10/17/2023 - 14:44pm
  • I-Mab provides update on TJ-L14B/ABL503 antibody developments

    10/10/2023 - 08:11am
  • I-Mab price target lowered to $23 from $24 at Needham

    9/25/2023 - 08:49am
  • I-Mab price target lowered to $18 from $25 at H.C. Wainwright

    8/18/2023 - 07:50am
  • Tracon Pharmaceuticals collects arbitration award from I-Mab

    7/11/2023 - 08:22am
  • I-Mab announces publication of givastomig in JITC

    7/5/2023 - 08:08am
  • I-Mab appoints Raj Kannan as CEO

    6/22/2023 - 08:02am
  • Cantor Fitzgerald biotech analyst to hold analyst/industry conference call

    6/9/2023 - 10:55am
  • Cantor Fitzgerald biotech analyst to hold analyst/industry conference call

    6/9/2023 - 04:55am
dynamic_feed Breaking News